<DOC>
	<DOCNO>NCT02072707</DOCNO>
	<brief_summary>The investigator hypothesize combined endocardial epicardial VT ablation use contact sensor irrigate catheter safe achieves low recurrence rate endocardial ablation ischemic non-ischemic patient , investigator randomize 20 patient two group , one endocardial ablation combine endocardial epicardial ablation .</brief_summary>
	<brief_title>Efficacy Safety Epicardial VT Ablation Using Contact Force Irrigated Tip Catheter - Pilot Study</brief_title>
	<detailed_description>Pilot Study Design The investigator select 20 ischemic non-ischemic cardiomyopathy patient scar relate Ventricular tachycardia indication VT ablation . After informed consent , patient randomize endocardial ( Control Group ) combine endocardial epicardial ablation ( Treatment Group ) . Inclusion Criteria Patients ischemic non-ischemic cardiomyopathy recurrent sustain monomorphic VT require cardioversion antiarrhythmic drug administration ≥4 episodes previous 6 month despite ICD antiarrhythmic drug therapy . Patients without ICD eligible 2 episode sustain VT. Exclusion Criteria Creatinine level &gt; 2.5mg/dL ; LV ejection fraction &lt; 10 % ; NYHA Class IV ; mobile thrombus LV ; absence vascular access LV ; life-expectancy le 12 month ; previous open-chest cardiac surgical procedure ; unstable angina ; myocardial infarction last 2 month ; severe aortic stenosis ; severe mitral regurgitation secondary leaflet chordae rupture ; pregnancy age less 18 year old . Ablation Technique In patient randomize combined epicardial endocardial ablation , subxyphoid puncture perform accord previously describe technique . Following successful epicardial access combine epi endocardial ablation follow venous puncture endocardial group , puncture femoral artery perform . If patient peripheral artery disease , catheter position left ventricle transeptal puncture . Electroanatomic voltage map construct endocardial epicardial surface . After map construction , program ventricular stimulation apex RV S4 extrastimuli perform aim VT inducibility . If induce VT well tolerate , activation mapping VT construct addition entrainment mapping . If VT hemodynamically tolerate , revert either Burst electrical cardioversion , substrate modification scar combine pace-mapping local abnormal electrograms ( late potential ) ablation perform . In patient endocardial group , endocardial surface right leave ventricle ablate . In combined epicardial endocardial group , choice surface ablate guided tachycardia mapping ( mesodiastolic pre-systolic potential ) , extension scar , pace-mapping surface . ECG criterion suggest epicardial surface also consider define epi endo surface ablate . Following ablation , repeat programmed ventricular stimulation S4 perform evaluated reinducibility VT. Additional RF application perform accord clinical criterion , procedure consider terminate VT inducible clinical criterion . In endo group endocardial scar could observe follow extensive endocardial ablation clinical VT still remain inducible , ECG criterion suggest epicardial VT underwent epicardial mapping ablation consider Cross-over . Outcomes Primary Outcome : Safety : The investigator evaluate rate complication relate irrigated tip catheter use epicardial surface . It expect combined epicardial endocardial ablation group present increase rate catheter-related complication . Efficacy : The investigator evaluate procedure succeed . The investigator consider success follow : ( 1 ) Complete Success : prevention induction VT follow ablation ; ( 2 ) Partial Success : prevention induction clinical VT , remain induction least one non-clinical faster VT ; ( 3 ) Failure : Remaining induction clinical initially induced VT . Secondary Outcome : Safety : The investigator evaluate rate complication relate epicardial access . It expect rate hemopericardium 20 % , le 5 % rate major complication procedure relate death , cardiac surgery due cardiac perforation blood cell transfusion .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>Patients ischemic nonischemic cardiomyopathy recurrent sustain monomorphic VT require cardioversion antiarrhythmic drug administration ≥4 episodes previous 6 month despite ICD antiarrhythmic drug therapy . Patients without ICD eligible 2 episode sustain VT. Creatinine level &gt; 2.5mg/dL LV ejection fraction &lt; 10 % NYHA Class IV Mobile thrombus LV Absence vascular access LV Lifeexpectancy le 12 month Previous openchest cardiac surgical procedure Unstable angina ; myocardial infarction last 2 month Severe aortic stenosis Severe mitral regurgitation secondary leaflet chordae rupture Pregnancy age less 18 year old .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ventricular Tachycardia</keyword>
	<keyword>RF ablation</keyword>
	<keyword>Epicardial Access</keyword>
	<keyword>Contact Sensor Irrigated tip catheter</keyword>
</DOC>